Search Results - "Dorman, Susan"

Refine Results
  1. 1

    Latent Tuberculosis Infection by Shah, Maunank, Dorman, Susan E

    Published in The New England journal of medicine (09-12-2021)
    “…Persons with risk factors for Mycobacterium tuberculosis exposure or for progression to tuberculosis disease should be tested for M. tuberculosis infection,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    New Diagnostic Tests for Tuberculosis: Bench, Bedside, and Beyond by Dorman, Susan E.

    Published in Clinical infectious diseases (15-05-2010)
    “…Current tools and strategies for diagnosis of tuberculosis (TB) are inadequate, particularly in settings with a high prevalence of human immunodeficiency virus…”
    Get full text
    Journal Article
  5. 5

    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study by Dorman, Susan E, Schumacher, Samuel G, Alland, David, Nabeta, Pamela, Armstrong, Derek T, King, Bonnie, Hall, Sandra L, Chakravorty, Soumitesh, Cirillo, Daniela M, Tukvadze, Nestani, Bablishvili, Nino, Stevens, Wendy, Scott, Lesley, Rodrigues, Camilla, Kazi, Mubin I, Joloba, Moses, Nakiyingi, Lydia, Nicol, Mark P, Ghebrekristos, Yonas, Anyango, Irene, Murithi, Wilfred, Dietze, Reynaldo, Lyrio Peres, Renata, Skrahina, Alena, Auchynka, Vera, Chopra, Kamal Kishore, Hanif, Mahmud, Liu, Xin, Yuan, Xing, Boehme, Catharina C, Ellner, Jerrold J, Denkinger, Claudia M, Dorman, Susan E, Schumacher, Samuel G, Alland, David, Nabeta, Pamela, Armstrong, Derek T, King, Bonnie, Hall, Sandra L, Chakravorty, Soumitesh, Cirillo, Daniela M, Tukvadze, Nestani, Bablishvili, Nino, Stevens, Wendy, Scott, Lesley, Rodrigues, Camilla, Kazi, Mubin I, Joloba, Moses, Nakiyingi, Lydia, Nicol, Mark P, Ghebrekristos, Yonas, Anyango, Irene, Murithi, Wilfred, Dietze, Reynaldo, Peres, Renata Lyrio, Skrahina, Alena, Auchynka, Vera, Chopra, Kamal Kishore, Hanif, Mahmud, Liu, Xin, Yuan, Xing, Boehme, Catharina C, Ellner, Jerrold J, Denkinger, Claudia M, Manabe, Yukari C, Hom, David, Aspindzelashvili, Rusudan, David, Anura, Surve, Utkarsha, Kamulegeya, Louis Henry, Nabweyambo, Sheila, Surtie, Shireen, Hapeela, Nchimunya, Cain, Kevin P, Agaya, Janet, McCarthy, Kimberly D, Marques-Rodrigues, Patricia, Schmidt Castellani, Luiz Guilherme, Almeida, Pedro Sousa, de Aguiar, Paola Poloni Lobo, Solodovnikova, Varvara, Ruan, Xianglin, Liang, Lili, Zhang, Guolong, Zhu, Hong, Xie, Yingda

    Published in The Lancet infectious diseases (01-01-2018)
    “…The Xpert MTB/RIF assay is an automated molecular test that has improved the detection of tuberculosis and rifampicin resistance, but its sensitivity is…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach by Burman, William, Rucsineanu, Oxana, Horsburgh, C Robert, Johnston, James, Dorman, Susan E, Menzies, Dick

    Published in PLoS medicine (25-07-2024)
    “…In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of…”
    Get full text
    Journal Article
  8. 8

    Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa by Shah, Maunank, Chihota, Violet, Coetzee, Gerrit, Churchyard, Gavin, Dorman, Susan E

    Published in BMC infectious diseases (29-07-2013)
    “…The World Health Organization has endorsed the use of molecular methods for the detection of TB and drug-resistant TB as a rapid alternative to culture-based…”
    Get full text
    Journal Article
  9. 9

    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics by Jakhar, Shailja, Sakamuri, Ramamurthy, Vu, Dung, Dighe, Priya, Stromberg, Loreen R, Lilley, Laura, Hengartner, Nicolas, Swanson, Basil I, Moreau, Emmanuel, Dorman, Susan E, Mukundan, Harshini

    Published in PloS one (07-04-2021)
    “…Lipoarabinomannan (LAM), an amphiphilic lipoglycan of the Mycobacterium tuberculosis cell wall, is a diagnostic target for tuberculosis. Previous work from our…”
    Get full text
    Journal Article
  10. 10

    Diagnosis of HIV-associated tuberculosis by Dorman, Susan E

    Published in Current opinion in HIV & AIDS (01-11-2018)
    “…PURPOSE OF REVIEWThe current review highlights recent advances in tuberculosis (TB) diagnostics that are relevant for clinicians engaged in the care of…”
    Get full text
    Journal Article
  11. 11

    Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection by Flume, Patrick A., Garcia, Bryan A., Wilson, Dulaney, Steed, Lisa, Dorman, Susan E., Winthrop, Kevin

    Published in Respiratory medicine (01-01-2023)
    “…There is an increasing prevalence of nontuberculous mycobacteria pulmonary disease (NTM-PD) in the US. Treatment of NTM-PD typically requires multiple…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection by Hibma, Jennifer E, Radtke, Kendra K, Dorman, Susan E, Jindani, Amina, Dooley, Kelly E, Weiner, Marc, McIlleron, Helen M, Savic, Radojka M

    “…Rifapentine has been investigated at various doses, frequencies, and dosing algorithms but clarity on the optimal dosing approach is lacking. In this…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis by van't Hoog, Anna H, Cobelens, Frank, Vassall, Anna, van Kampen, Sanne, Dorman, Susan E, Alland, David, Ellner, Jerrold

    Published in PloS one (18-12-2013)
    “…High costs are a limitation to scaling up the Xpert MTB/RIF assay (Xpert) for the diagnosis of tuberculosis in resource-constrained settings. A triaging…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Four-Month Rifapentine Regimens for Tuberculosis by Taylor, Andrew, Woodrow, Charles, Phillips, Patrick P.J, Kurbatova, Ekaterina V, Dorman, Susan E

    Published in The New England journal of medicine (17-03-2022)
    “…To the Editor: Dorman et al. (May 6 issue) 1 found that a 4-month rifapentine-based, moxifloxacin-containing regimen was noninferior to the standard 6-month…”
    Get full text
    Journal Article
  19. 19
  20. 20

    From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis by Dorman, Susan E, Chaisson, Richard E

    Published in Nature medicine (01-03-2007)
    “…Extensively drug-resistant tuberculosis (XDR-TB) occurs where health systems have been historically weak; it lays bare the reality of TB as a serious public…”
    Get full text
    Journal Article